vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and Worksport Ltd (WKSP). Click either name above to swap in a different company.

CRYO CELL INTERNATIONAL INC is the larger business by last-quarter revenue ($7.8M vs $4.7M, roughly 1.7× Worksport Ltd). On growth, Worksport Ltd posted the faster year-over-year revenue change (62.0% vs -2.3%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $-6.3M). Over the past eight quarters, Worksport Ltd's revenue compounded faster (204.2% CAGR vs -0.1%).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

Worksport Ltd is a cleantech company specializing in portable solar energy solutions and custom truck bed accessories. Its core offerings include solar-powered tonneau covers for pickup trucks and portable mobile power stations, serving the North American automotive aftermarket and consumer clean energy segments.

CCEL vs WKSP — Head-to-Head

Bigger by revenue
CCEL
CCEL
1.7× larger
CCEL
$7.8M
$4.7M
WKSP
Growing faster (revenue YoY)
WKSP
WKSP
+64.3% gap
WKSP
62.0%
-2.3%
CCEL
More free cash flow
CCEL
CCEL
$7.5M more FCF
CCEL
$1.2M
$-6.3M
WKSP
Faster 2-yr revenue CAGR
WKSP
WKSP
Annualised
WKSP
204.2%
-0.1%
CCEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCEL
CCEL
WKSP
WKSP
Revenue
$7.8M
$4.7M
Net Profit
$-3.8M
Gross Margin
77.9%
30.1%
Operating Margin
-50.6%
-129.6%
Net Margin
-48.7%
Revenue YoY
-2.3%
62.0%
Net Profit YoY
-105.1%
EPS (diluted)
$-0.46
$-0.65

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
WKSP
WKSP
Q4 25
$7.8M
$4.7M
Q3 25
$7.8M
$5.0M
Q2 25
$7.9M
$4.1M
Q1 25
$8.0M
$2.2M
Q4 24
$8.0M
$2.9M
Q3 24
$8.1M
$3.1M
Q2 24
$8.0M
$1.9M
Q1 24
$7.9M
$512.6K
Net Profit
CCEL
CCEL
WKSP
WKSP
Q4 25
$-3.8M
Q3 25
$749.4K
$-4.9M
Q2 25
$355.8K
$-3.7M
Q1 25
$282.9K
$-4.5M
Q4 24
$-1.9M
Q3 24
$1.1M
$-4.1M
Q2 24
$655.8K
$-4.0M
Q1 24
$556.2K
$-3.7M
Gross Margin
CCEL
CCEL
WKSP
WKSP
Q4 25
77.9%
30.1%
Q3 25
77.0%
31.3%
Q2 25
76.6%
26.4%
Q1 25
75.1%
17.7%
Q4 24
78.4%
11.1%
Q3 24
73.6%
7.9%
Q2 24
74.8%
15.4%
Q1 24
73.7%
7.3%
Operating Margin
CCEL
CCEL
WKSP
WKSP
Q4 25
-50.6%
-129.6%
Q3 25
24.3%
-95.6%
Q2 25
18.8%
-88.1%
Q1 25
13.3%
-190.0%
Q4 24
-1.5%
-137.0%
Q3 24
17.2%
-125.1%
Q2 24
17.3%
-203.5%
Q1 24
10.5%
-709.9%
Net Margin
CCEL
CCEL
WKSP
WKSP
Q4 25
-48.7%
Q3 25
9.6%
-98.3%
Q2 25
4.5%
-91.0%
Q1 25
3.5%
-199.1%
Q4 24
-23.2%
Q3 24
13.0%
-132.4%
Q2 24
8.2%
-208.9%
Q1 24
7.1%
-724.6%
EPS (diluted)
CCEL
CCEL
WKSP
WKSP
Q4 25
$-0.46
$-0.65
Q3 25
$0.09
$-0.75
Q2 25
$0.04
$-0.71
Q1 25
$0.03
$-1.05
Q4 24
$-0.23
$-1.14
Q3 24
$0.13
$-1.40
Q2 24
$0.08
$-1.55
Q1 24
$0.07
$-1.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
WKSP
WKSP
Cash + ST InvestmentsLiquidity on hand
$3.3M
$5.9M
Total DebtLower is stronger
$8.4M
$2.7M
Stockholders' EquityBook value
$-18.6M
$22.9M
Total Assets
$61.7M
$30.7M
Debt / EquityLower = less leverage
0.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
WKSP
WKSP
Q4 25
$3.3M
$5.9M
Q3 25
$3.2M
$3.8M
Q2 25
$4.4M
$1.4M
Q1 25
$3.5M
$5.1M
Q4 24
$3.5M
$4.9M
Q3 24
$2.1M
$1.9M
Q2 24
$1.5M
$3.4M
Q1 24
$979.6K
$3.5M
Total Debt
CCEL
CCEL
WKSP
WKSP
Q4 25
$8.4M
$2.7M
Q3 25
$8.4M
$2.9M
Q2 25
$8.4M
$2.5M
Q1 25
$8.5M
$3.1M
Q4 24
$8.5M
$5.3M
Q3 24
$8.5M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
CCEL
CCEL
WKSP
WKSP
Q4 25
$-18.6M
$22.9M
Q3 25
$-14.8M
$19.8M
Q2 25
$-15.6M
$17.3M
Q1 25
$-14.7M
$20.1M
Q4 24
$-13.2M
$17.4M
Q3 24
$-9.6M
$16.4M
Q2 24
$-10.7M
$19.1M
Q1 24
$-10.3M
$18.9M
Total Assets
CCEL
CCEL
WKSP
WKSP
Q4 25
$61.7M
$30.7M
Q3 25
$63.2M
$27.0M
Q2 25
$64.4M
$23.6M
Q1 25
$64.4M
$26.7M
Q4 24
$64.7M
$25.7M
Q3 24
$62.9M
$24.9M
Q2 24
$62.6M
$27.2M
Q1 24
$61.7M
$27.3M
Debt / Equity
CCEL
CCEL
WKSP
WKSP
Q4 25
0.12×
Q3 25
0.15×
Q2 25
0.14×
Q1 25
0.16×
Q4 24
0.30×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
WKSP
WKSP
Operating Cash FlowLast quarter
$1.3M
$-6.1M
Free Cash FlowOCF − Capex
$1.2M
$-6.3M
FCF MarginFCF / Revenue
15.5%
-132.4%
Capex IntensityCapex / Revenue
0.9%
3.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.2M
$-18.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
WKSP
WKSP
Q4 25
$1.3M
$-6.1M
Q3 25
$2.5M
$-4.3M
Q2 25
$707.0K
$-3.1M
Q1 25
$954.1K
$-3.8M
Q4 24
$2.2M
$-2.2M
Q3 24
$2.4M
$-1.5M
Q2 24
$1.8M
$-3.6M
Q1 24
$-356.9K
$-2.8M
Free Cash Flow
CCEL
CCEL
WKSP
WKSP
Q4 25
$1.2M
$-6.3M
Q3 25
$2.5M
$-4.6M
Q2 25
$644.6K
$-3.2M
Q1 25
$892.0K
$-4.0M
Q4 24
$2.1M
$-2.2M
Q3 24
$2.3M
$-1.7M
Q2 24
$21.5K
$-3.7M
Q1 24
$-814.6K
$-3.0M
FCF Margin
CCEL
CCEL
WKSP
WKSP
Q4 25
15.5%
-132.4%
Q3 25
31.9%
-92.1%
Q2 25
8.1%
-77.1%
Q1 25
11.2%
-180.4%
Q4 24
26.8%
-75.4%
Q3 24
27.9%
-54.5%
Q2 24
0.3%
-195.1%
Q1 24
-10.4%
-586.7%
Capex Intensity
CCEL
CCEL
WKSP
WKSP
Q4 25
0.9%
3.3%
Q3 25
0.5%
7.3%
Q2 25
0.8%
1.7%
Q1 25
0.8%
9.0%
Q4 24
0.1%
0.9%
Q3 24
2.3%
5.3%
Q2 24
21.8%
6.4%
Q1 24
5.8%
41.5%
Cash Conversion
CCEL
CCEL
WKSP
WKSP
Q4 25
Q3 25
3.38×
Q2 25
1.99×
Q1 25
3.37×
Q4 24
Q3 24
2.32×
Q2 24
2.70×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons